Article ID Journal Published Year Pages File Type
10968239 Vaccine 2012 4 Pages PDF
Abstract
► We estimated the annual direct medical costs attributable to HPV in the USA. ► The overall annual direct medical cost burden was estimated to be $8.0 billion. ► Most of this cost was for cervical cancer screening and follow-up ($6.6 billion).
Keywords
Related Topics
Life Sciences Immunology and Microbiology Immunology
Preview
Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States
Authors
, , , , , ,